120 related articles for article (PubMed ID: 10849729)
1. Enzymatic activity is not a precondition for the intracellular calcium increase mediated by mAbs specific for aminopeptidase N/CD13.
Navarrete Santos A; Langner J; Riemann D
Adv Exp Med Biol; 2000; 477():43-7. PubMed ID: 10849729
[No Abstract] [Full Text] [Related]
2. Suppression of splenic enzyme activities by administration of aminopeptidase N (CD13) inhibitors: relationship between actions in vivo and in vitro.
Kocha T; Ohtsuka E; Funahashi T; Fukuda T; Aoyagi T; Wanda T; Takeuchi T
J Enzyme Inhib; 1994; 8(3):187-95. PubMed ID: 7539487
[TBL] [Abstract][Full Text] [Related]
3. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.
Bauvois B; Dauzonne D
Med Res Rev; 2006 Jan; 26(1):88-130. PubMed ID: 16216010
[TBL] [Abstract][Full Text] [Related]
4. Aminopeptidase N (CD13) as a target for cancer chemotherapy.
Wickström M; Larsson R; Nygren P; Gullbo J
Cancer Sci; 2011 Mar; 102(3):501-8. PubMed ID: 21205077
[TBL] [Abstract][Full Text] [Related]
5. Induction of the membrane alanyl aminopeptidase gene and surface expression in human T-cells by mitogenic activation.
Lendeckel U; Wex T; Reinhold D; Kähne T; Frank K; Faust J; Neubert K; Ansorge S
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):817-21. PubMed ID: 8920985
[TBL] [Abstract][Full Text] [Related]
6. Effect of ubenimex (Bestatin) on the cell growth and phenotype of HL-60 and HL-60R cell lines: up-and down-regulation of CD13/aminopeptidase N.
Imamura N; Kimura A
Leuk Lymphoma; 2000 May; 37(5-6):663-7. PubMed ID: 11042531
[TBL] [Abstract][Full Text] [Related]
7. Role of CD13/aminopeptidase N in rat lymphocytic alveolitis caused by thoracic irradiation.
Huang L; Tani K; Ogushi F; Ogawa H; Shimizu T; Motoki Y; Moriguchi H; Sone S
Radiat Res; 2002 Feb; 157(2):191-8. PubMed ID: 11835683
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle retardation in monocytoid cells induced by aminopeptidase N (CD13).
Löhn M; Mueller C; Langner J
Leuk Lymphoma; 2002 Feb; 43(2):407-13. PubMed ID: 11999577
[TBL] [Abstract][Full Text] [Related]
9. CD13 in cell adhesion: aminopeptidase N (CD13) mediates homotypic aggregation of monocytic cells.
Mina-Osorio P; Shapiro LH; Ortega E
J Leukoc Biol; 2006 Apr; 79(4):719-30. PubMed ID: 16415167
[TBL] [Abstract][Full Text] [Related]
10. New Method for Detecting the Suppressing Effect of Enzyme Activity by Aminopeptidase N Inhibitor.
Liu H; Wang X; Yang H; Zhao Y; Ji S; Ma H; Zhou Y; Wang Y; Zhang H; Jiang W; Fang C; Feng L; Wang X
Chem Pharm Bull (Tokyo); 2019; 67(2):155-158. PubMed ID: 30713276
[TBL] [Abstract][Full Text] [Related]
11. Novel small molecule nonpeptide aminopeptidase n inhibitors with a cyclic imide skeleton.
Shimazawa R; Takayama H; Fujimoto Y; Komoda M; Dodo K; Yamasaki R; Shirai R; Koiso Y; Miyata K; Kato F; Kato M; Miyachi H; Hashimoto Y
J Enzyme Inhib; 1999; 14(4):259-75. PubMed ID: 10445048
[TBL] [Abstract][Full Text] [Related]
12. The role of aminopeptidase N in Met-enkephalin modulated superoxide anion release.
Balog T; Marotti T; Abramić M; Svoboda-Beusen I; Hrsak I
Immunopharmacology; 1999 Jan; 41(1):11-20. PubMed ID: 9950265
[TBL] [Abstract][Full Text] [Related]
13. CD13/aminopeptidase N and murine cytomegalovirus infection.
Kasman LM
Virology; 2005 Mar; 334(1):1-9. PubMed ID: 15749117
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel chloramphenicol amine derivatives as potent aminopeptidase N (APN/CD13) inhibitors.
Yang K; Wang Q; Su L; Fang H; Wang X; Gong J; Wang B; Xu W
Bioorg Med Chem; 2009 Jun; 17(11):3810-7. PubMed ID: 19423354
[TBL] [Abstract][Full Text] [Related]
15. A role for galectin-3 in CD13-mediated homotypic aggregation of monocytes.
Mina-Osorio P; Soto-Cruz I; Ortega E
Biochem Biophys Res Commun; 2007 Feb; 353(3):605-10. PubMed ID: 17189612
[TBL] [Abstract][Full Text] [Related]
16. Aminopeptidase N inhibitors and SARS.
Kontoyiannis DP; Pasqualini R; Arap W
Lancet; 2003 May; 361(9368):1558. PubMed ID: 12737884
[No Abstract] [Full Text] [Related]
17. Inactivation of interleukin-8 by aminopeptidase N (CD13).
Kanayama N; Kajiwara Y; Goto J; el Maradny E; Maehara K; Andou K; Terao T
J Leukoc Biol; 1995 Jan; 57(1):129-34. PubMed ID: 7829964
[TBL] [Abstract][Full Text] [Related]
18. Leukemic cell-surface CD13/aminopeptidase N and resistance to apoptosis mediated by endothelial cells.
Mishima Y; Matsumoto-Mishima Y; Terui Y; Katsuyama M; Yamada M; Mori M; Ishizaka Y; Ikeda K; Watanabe J; Mizunuma N; Hayasawa H; Hatake K
J Natl Cancer Inst; 2002 Jul; 94(13):1020-8. PubMed ID: 12096087
[TBL] [Abstract][Full Text] [Related]
19. Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry.
Cao J; Ma C; Zang J; Gao S; Gao Q; Kong X; Yan Y; Liang X; Ding Q; Zhao C; Wang B; Xu W; Zhang Y
Bioorg Med Chem; 2018 Jul; 26(12):3145-3157. PubMed ID: 29859750
[TBL] [Abstract][Full Text] [Related]
20. Aminopeptidase N-mediated signal transduction and inhibition of proliferation of human myeloid cells.
Löhn M; Mueller C; Thiele K; Kähne T; Riemann D; Langner J
Adv Exp Med Biol; 1997; 421():85-91. PubMed ID: 9330684
[No Abstract] [Full Text] [Related]
[Next] [New Search]
